Mobia Medical, Inc. (NASDAQ:MOBI) Receives $20.75 Consensus PT from Analysts

Shares of Mobia Medical, Inc. (NASDAQ:MOBI) have received a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $20.75.

A number of research analysts have recently issued reports on MOBI shares. The Goldman Sachs Group started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set a “buy” rating and a $31.00 price objective for the company. Zacks Research raised shares of Mobia Medical to a “hold” rating in a research report on Wednesday, June 3rd. Wall Street Zen raised Mobia Medical from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. JPMorgan Chase & Co. increased their price objective on Mobia Medical from $15.00 to $17.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Finally, Weiss Ratings assumed coverage on Mobia Medical in a research report on Wednesday, August 12th. They set a “sell (e-)” rating on the stock.

Mobia Medical Stock Performance

Shares of MOBI stock opened at $10.95 on Friday. The company has a market capitalization of $364.54 million and a P/E ratio of -0.54. Mobia Medical has a fifty-two week low of $10.19 and a fifty-two week high of $15.29. The business has a 50 day simple moving average of $12.35. The company has a debt-to-equity ratio of 0.04, a quick ratio of 12.80 and a current ratio of 13.28.

Mobia Medical (NASDAQ:MOBI) last released its earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.27). The company had revenue of $13.51 million for the quarter. The business’s revenue for the quarter was up 102.4% on a year-over-year basis. On average, research analysts predict that Mobia Medical will post -2.76 earnings per share for the current year.

Insider Buying and Selling at Mobia Medical

In other news, Director Casey M. Tansey bought 35,572 shares of the stock in a transaction dated Thursday, August 13th. The stock was bought at an average price of $11.51 per share, for a total transaction of $409,433.72. Following the completion of the acquisition, the director directly owned 268,904 shares in the company, valued at approximately $3,095,085.04. This trade represents a 15.25% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Nelson Bunker Curnes purchased 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 9th. The shares were purchased at an average cost of $12.79 per share, for a total transaction of $63,950.00. Following the completion of the transaction, the chief financial officer directly owned 366,997 shares of the company’s stock, valued at $4,693,891.63. This represents a 1.38% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have acquired 90,000 shares of company stock worth $1,059,717.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.